Clinical Trials Logo

Other clinical trials

View clinical trials related to Other.

Filter by:

NCT ID: NCT03932188 Enrolling by invitation - Clinical trials for Mental Health Issue (E.G., Depression, Psychosis, Personality Disorder, Substance Abuse)

Brain Imaging in Early Psychosis

Start date: September 1, 2020
Phase:
Study type: Observational

This study assesses brain connectivity and function of individuals ages 13-25 at a prodromal or early stage of a psychotic disorder. Participation involves approximately 3 hours of MRI scanning and up to 6 hours of behavioral testing at Washington University School of Medicine's campus.

NCT ID: NCT03930810 Enrolling by invitation - Clinical trials for Progressive Familial Intrahepatic Cholestasis

NAtural Course and Prognosis of PFIC and Effect of Biliary Diversion

NAPPED
Start date: January 26, 2017
Phase:
Study type: Observational

The natural course of PFIC syndromes and the effect of diversion techniques, have so far not been characterized in a rigorous manner within a larger population of patients. In fact, the clinical or biochemical parameters which most directly define and/or predict the success of reduced enterohepatic circulation (either by surgical diversion or medically) are still unclear. The present project aims to: 1. Define the natural course of disease in genetically defined PFIC1, and PFIC2 patients, with respect to relevant biochemical and clinical parameters (and if available, histological). Included will be patients homozygous for a known, disease-causing mutation, patients compound homozygous for two disease-causing mutations or heterozygous for one disease-causing mutation in combination with the clinical phenotype of Bsep-deficiency or FIC1-deficiency. 2. Define the change in the natural course of disease in response to biliary diversion surgery and or liver transplantation, based on short- and long(er)-term changes in biochemical (if available, histological) and clinical parameters, including outcome measures. Follow up after transplantation will be limited to max 3 months after transplant surgery, follow up after surgical biliary diversion will be as long as possible. 3. Assessment of biochemical variables as possible surrogate endpoints for clinical hard endpoints. If possible this allows for identification of low-risk to high-risk patients early during follow-up. 4. If patient numbers permit, to establish genotype-phenotype relationships for the most common genetic mutations causing Bsep-deficiency or FIC1-deficiency. Based on this project it is anticipated that the investigators are able: - to characterize the variation in natural course of disease (whether or not genotype dependent) to allow clinicians to rationally select a target population for assessing the effect of medical intervention, rather than surgical biliary diversion); - to identify and qualify one or more biomarkers that independently predict either improved or poor clinical outcomes of surgical biliary diversion; - to investigate if the identified biomarker(s) can be used as surrogate end point(s) for assessing and predicting outcomes with novel interventional strategies.

NCT ID: NCT03924934 Enrolling by invitation - Clinical trials for Enterobacteriaceae Infections

Community-associated Highly-Resistant Enterobacterales

COCARE
Start date: May 1, 2019
Phase:
Study type: Observational

This is a prospective multi-center study. Bacterial isolates from hospitalized patients with CA-HRE will be compared to those from hospitalized patients with healthcare-associated HRE (HA-HRE). In addition, community spread of CRE will be determined.

NCT ID: NCT03923777 Enrolling by invitation - Clinical trials for Stage IA Non-small Cell Lung Cancer

Active Surveillance in Early Lung Cancer

ACTION-Lung
Start date: July 31, 2018
Phase: N/A
Study type: Interventional

Cancer patients are often given the choice of delaying or avoiding treatment as one of their options. However, there is not much information guiding lung cancer patients and their clinicians regarding this approach. Active surveillance is a way of either delaying or avoiding treatment and its possible side effects through carefully watching for changes in the tumor and considering treatment if there is progression. The purpose of this research study is to evaluate active surveillance and ways to better understand if and when to treat patients with stage IA lung cancer.

NCT ID: NCT03918590 Enrolling by invitation - Clinical trials for Diabetic Macular Edema

Post Intravitreal Injection Topical NSAID vs. Patching

Start date: December 3, 2018
Phase: Phase 4
Study type: Interventional

A prospective randomized trial, to evaluate post-injection comfort measures comparing topical NSAID (nepafenac 0.3% suspension) and patching.

NCT ID: NCT03914768 Enrolling by invitation - Clinical trials for Diffuse Intrinsic Pontine Glioma or Glioblastoma

Immune Modulatory DC Vaccine Against Brain Tumor

Start date: March 31, 2019
Phase: Phase 1
Study type: Interventional

This study is designed to treat patients who have been diagnosed with brain cancer, including glioblastoma (GBM) and diffuse intrinsic pontine glioma (DIPG). The treatment uses immunomodulatory vaccine generated by autologous dendritic cells (DCs) pulsed with genetically modified tumor cells or tumor-related antigens including neoantigens to inject into patients. Vaccine-induced T cell responses have been associated with improved survival. The study will evaluate the safety and potential benefit of the novel immunomodulatory DC vaccines.

NCT ID: NCT03903978 Enrolling by invitation - Clinical trials for Waiting List Control

Efficacy and Effectiveness of a Self-applied Online Program to Promote Resilience and Coping Skills in College Students

Start date: November 1, 2018
Phase: N/A
Study type: Interventional

This study aims to evaluate the effectiveness and efficiency of this intervention protocol applied to three populations of Spanish-speaking university students (Spain, Argentina and Mexico). The purpose of this paper is to present the protocol designed to carry out the randomised controlled study (RCT).

NCT ID: NCT03901521 Enrolling by invitation - Clinical trials for Autosomal Dominant Polycystic Kidney Disease

Autosomal Dominant Polycystic Kidney Disease Somatic Mutation Biorepository

ADPKD
Start date: June 1, 2018
Phase:
Study type: Observational [Patient Registry]

This study will analyze the germline and somatic mutations underlying the development of ADPKD in order to better understand the genetic mechanism responsible for the cystic transformation. Once identified, these mutations could help us understand better the mechanism leading to the development of this disease and may explain at least in part the phenotypic variability.

NCT ID: NCT03896763 Enrolling by invitation - Clinical trials for Acute Respiratory Distress Syndrome in Children

PROSpect: Prone and Oscillation Pediatric Clinical Trial

Start date: May 1, 2019
Phase: N/A
Study type: Interventional

Severe pediatric acute respiratory distress syndrome (PARDS) is a life-threatening and frequent problem experienced by thousands of children each year. Little evidence supports current supportive practices during their critical illness. The overall objective of this study is to identify the best positional and/or ventilation practice that leads to improved patient outcomes in these critically ill children. We hypothesize that children with high moderate-severe PARDS treated with either prone positioning or high-frequency oscillatory ventilation (HFOV) will demonstrate more days off the ventilator when compared to children treated with supine positioning or conventional mechanical ventilation (CMV).

NCT ID: NCT03895164 Enrolling by invitation - Anemia Clinical Trials

Linear Programming Approach to Develop Local Specific Food-based Complementary Feeding Recommendation

Start date: December 19, 2018
Phase: N/A
Study type: Interventional

Stunting and anemia amongst under-two children are attributable to poor nutrient intakes. The study evaluates the effectiveness of nutrition education on local specific food-based complementary feeding recommendation (CFR) to improve dietary patterns and nutritional intakes, as well as reduce stunting and anemia among under-two children.